Dr. Staveley-O'Carroll is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
263 Farmington Ave
Farmington, CT 06030Phone+1 860-679-8080Fax+1 860-679-1340
Summary
- Dr. Kevin Staveley-O'Carroll is a surgical oncologist in Farmington, CT, affiliated with UConn Health, John Dempsey Hospital. He specializes in treating patients with liver, pancreas, and foregut tumors.
Education & Training
- The Military College of South Carolina, The CitadelMBA, 2015 - 2017
- The Johns Hopkins HospitalSurgical Oncology, 1999 - 2000
- Johns Hopkins UniversityChief Residency, Surgery, 1998 - 1999
- Johns Hopkins UniversityResidency, Surgery, 1990 - 1999
- Royal College of SurgeonsRegistrar in Vascular/Thoracic Surgery, 1998 - 1998
- Johns Hopkins UniversityFellowship, Research, 1992 - 1996
- University of Oklahoma College of MedicineClass of 1990
- University of Notre DameB.S., Chemistry, 1986
Certifications & Licensure
- CT State Medical License 2023 - 2025
- MO State Medical License 2015 - 2025
- SC State Medical License 2013 - 2025
- PA State Medical License 2000 - 2014
- MD State Medical License 1993 - 2001
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Marion S. DeWeese, MD, Excellence in Arts and Science in the Operating Room 2022
- Moses Gunn Distinguished Professor University of Michigan, 2013
- Visiting Professorship Trinity College, 2011
- Join now to see all
Publications & Presentations
PubMed
- 19 citationsSilencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancerYuanke Li, Zhen Zhao, Chien Yu Lin, Yanli Liu, Kevin F. Staveley-O’Carroll
Theranostics. 2021-01-01
Journal Articles
- Impact of Genetic Targets on Cancer Therapy: Hepatocellular CancerHamed O, Kimchi ET, Sehmbey M, Gusani NJ, Kaifi JT, Staveley-O'Carroll K, Adv Exp Med Biol, 1/1/2013
- A Handy Tool to Teach Segmental Liver Anatomy to Surgical TraineesPauli EM, Staveley-O'Carroll KF, Brock MV, Efron DT, Efron G, Archives of Surgery, 8/1/2012
- Circulating tumor cells in melanoma patientsClawson GA, Kimchi E, Patrick SD, Xin P, Harouaka R, Zheng S, Berg A, Schell T, Staveley-O'Carroll KF, Neves RI, Mosca PJ, Thiboutot D, PLoS One, 7/19/2012
- Join now to see all
Grant Support
- Targeting KLF2 in macrophages to improve immune checkpoint therapy for hepatocellular cancerUNIVERSITY OF CONNECTICUT SCH OF MED/DNT2024–2029
- Targeting KLF2 in macrophages to improve immune checkpoint therapy for hepatocellular cancerUNIVERSITY OF CONNECTICUT SCH OF MED/DNT2023–2029
- Targeting KLF2 in macrophages to improve immune checkpoint therapy for hepatocellular cancerUNIVERSITY OF CONNECTICUT SCH OF MED/DNT2023–2029
- Targeting KLF2 in macrophages to improve immune checkpoint therapy for hepatocellular cancerUNIVERSITY OF CONNECTICUT SCH OF MED/DNT2023–2029
- Mechanistic studies of gut microbiota-mediated immune activation against hepatocellular cancerUNIVERSITY OF CONNECTICUT SCH OF MED/DNT2021–2026
- Mechanisms of gut microbiota/metabolite interface-mediated hepatic inflammationUNIVERSITY OF CONNECTICUT SCH OF MED/DNT2022–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: